124 related articles for article (PubMed ID: 7986686)
21. Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.
Papalas JA; Van Mater D; Wang E
Am J Dermatopathol; 2010 Dec; 32(8):821-7. PubMed ID: 20881832
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy.
Querfeld C; Kuzel TM; Guitart J; Rosen ST
Oncology (Williston Park); 2007 May; 21(6):689-96; discussion 699-700,. PubMed ID: 17564326
[TBL] [Abstract][Full Text] [Related]
23. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
24. Clinical features of CD30 (Ki-1) positive anaplastic large-cell lymphoma (ALCL). Review of the literature.
de Kan R; van 't Veer MB
Neth J Med; 1993 Dec; 43(5-6):277-84. PubMed ID: 8107936
[TBL] [Abstract][Full Text] [Related]
25. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
[TBL] [Abstract][Full Text] [Related]
26. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
27. The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants.
Massone C; El-Shabrawi-Caelen L; Kerl H; Cerroni L
J Cutan Pathol; 2008 Jan; 35(1):46-53. PubMed ID: 18095994
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.
Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker S
Genes Chromosomes Cancer; 2003 Jun; 37(2):176-85. PubMed ID: 12696066
[TBL] [Abstract][Full Text] [Related]
29. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
Kempf W
J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
[TBL] [Abstract][Full Text] [Related]
30. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
32. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous CD30-positive lymphoproliferative disorders.
Willemze R; Meijer CJ
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1319-32, vii-viii. PubMed ID: 14710887
[TBL] [Abstract][Full Text] [Related]
34. [Adult's anaplastic CD30+ large cell lymphomas].
Cany L; Soubeyran P; Boulanger V; Soubeyran I; Richaud P; Eghbali H; Hoerni B
Bull Cancer; 1999 Sep; 86(9):739-44. PubMed ID: 10519967
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic large cell lymphoma of scrotal skin.
Mehdi I; Praseeda I; Al-Bahrani BJ; Satayapal N; Monem AA; Al Kharusi S
J Pak Med Assoc; 2011 Nov; 61(11):1140-3. PubMed ID: 22126000
[TBL] [Abstract][Full Text] [Related]
36. [Ki-1-positive anaplastic large-cell lymphoma. Clinical significance].
Ribera JM; Feliu E
Sangre (Barc); 1995 Aug; 40(4):261-3. PubMed ID: 7482112
[No Abstract] [Full Text] [Related]
37. Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 cases.
Bernier M; Bagot M; Broyer M; Farcet JP; Gaulard P; Wechsler J
J Cutan Pathol; 1997 Mar; 24(3):157-63. PubMed ID: 9085151
[TBL] [Abstract][Full Text] [Related]
38. Superimposed linear graft-versus-host disease and secondary cutaneous involvement of anaplastic large cell lymphoma.
Oiso N; Tatsumi Y; Rai S; Matsumura I; Kawada A
Eur J Dermatol; 2011; 21(4):636-8. PubMed ID: 21697052
[No Abstract] [Full Text] [Related]
39. Primary cutaneous anaplastic large cell lymphoma with leg involvement: a case report and review of 11 cases.
Sugaya M; Fujita H; Izutsu K; Oshima K; Takazawa Y; Ohmatsu H; Yoshimi A; Takahashi T; Kanda Y; Kurokawa M; Tamaki K; Sato S
J Dermatol; 2011 Oct; 38(10):1009-12. PubMed ID: 21434982
[No Abstract] [Full Text] [Related]
40. CD30+ lymphoproliferative disorders of the skin: still an open question.
Alaibac M; Zarian H; Russo I; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):545-52. PubMed ID: 23149700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
